i-124-clr1404
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT01898273)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
- Payload
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- i-124-clr1404
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01898273 | Phase 2 | Feb 1, 2014 | Cellectar, Inc, City of Hope National Medical Center, University of Pennsylvania, University of Wisconsin |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cellectar, Inc | For profit | 1 | 1 | 1 | 2014 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1